| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |